Purchases and Sales Made in Q4 2023 in Aptevo Therapeutics Inc. (APVO)
This table provides information about the institutional ownership of Aptevo Therapeutics Inc. (APVO) during Q4 2023. The information is specifically focused on institutions that hold shares of Aptevo Therapeutics Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2024
Q4 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
341K+ 193.66% |
$57.9K - $130K
|
517K
$2.49M
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
262KNew |
$44.6K - $99.6K
|
262K
$1.26M
|
|
|
Feb 14, 2024
Q4 2023
|
Squarepoint Ops LLC
New York, NY |
BUY
|
- |
139KNew |
$23.6K - $52.7K
|
139K
$667K
|
|
|
Feb 14, 2024
Q4 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
105KNew |
$17.8K - $39.8K
|
105K
$503K
|
|
|
Feb 14, 2024
Q4 2023
|
Schonfeld Strategic Advisors LLC
New York, NY |
BUY
|
- |
16.2K+ 11.34% |
$2.75K - $6.16K
|
159K
$765K
|
|
|
Feb 08, 2024
Q4 2023
|
Baader Bank Aktiengesellschaft
Unterschleissheim, 2M |
BUY
|
- |
15.1KNew |
$2.56K - $5.73K
|
15.1K
$72.6K
|
|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
11.4KNew |
$1.93K - $4.32K
|
11.4K
$54.7K
|
|
|
Feb 14, 2024
Q4 2023
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
- |
11.2KNew |
$1.91K - $4.27K
|
11.2K
$54.1K
|
|
|
Dec 26, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
1.9KNew |
$322 - $721
|
1.9K
$9.12K
|
|
|
Feb 13, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
357+ 3.24% |
$60.7 - $136
|
11.4K
$54.7K
|
|
|
Feb 13, 2024
Q4 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
165+ 1.22% |
$28.1 - $62.7
|
13.7K
$65.7K
|
|
|
Feb 09, 2024
Q4 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
55+ 3.52% |
$9.35 - $20.9
|
1.62K
$7.78K
|
|
|
Feb 07, 2024
Q4 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 12, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-10- 0.52% |
$1.7 - $3.8
|
1.9K
$9.12K
|
|
|
Feb 09, 2024
Q4 2023
|
Ubs Group Ag
|
SELL
|
- |
-80- 94.12% |
$13.6 - $30.4
|
5
$24
|
|
|
Feb 13, 2024
Q4 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-1.03K- 2.17% |
$176 - $393
|
46.6K
$224K
|
|
|
Feb 13, 2024
Q4 2023
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-32.2K- 42.67% |
$5.47K - $12.2K
|
43.2K
$208K
|
|
|
Feb 14, 2024
Q4 2023
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-129K- 58.51% |
$22K - $49.1K
|
91.7K
$441K
|
|
|
Feb 14, 2024
Q4 2023
|
Cantor Fitzgerald, L. P.
New York, NY |
SELL
|
- |
-193K- 76.69% |
$32.7K - $73.2K
|
58.5K
$282K
|
|
|
Feb 14, 2024
Q4 2023
|
Sabby Management, LLC
Upper Saddle River, NJ |
SELL
|
- |
-985K- 73.81% |
$167K - $374K
|
349K
$1.68M
|
|
|
Feb 13, 2024
Q4 2023
|
Armistice Capital, LLC
New York, NY |
SELL
|
- |
-1.17M- 95.05% |
$200K - $446K
|
61.1K
$294K
|